Please login to the form below
Glenmark
This page shows the latest Glenmark news and features for those working in and with pharma, biotech and healthcare.
Riva leaves Gilead to head Glenmark’s innovation spin-off
Company has own bispecific antibody platform. Indian pharma company Glenmark has appointed Alessandro Riva as the chief executive of its new spin-off company focused on innovative medicines. ... Glenmark’s business is dominated by its presence in
Latest news
-
Gilead and ViiV among winners at PM Society Digital Awards
Allergan, Glenmark, Grunenthal, Merck Serono, MSD and Novartis and all won Gold as well.
-
EMA suspends generic drugs on data integrity concerns
Included in the lengthy list of medicines affected by the suspension are products sold by Sandoz, Teva, Mylan, Sanofi, Biogaran Ratiopharm, Glenmark and Accord Healthcare, amongst many other firms, and most
-
Indian court blocks generic of Merck's Januvia
India's Supreme Court has prevented Glenmark Pharmaceuticals from making and selling a generic of Merck &Co's diabetes blockbuster Januvia. ... Glenmark was ordered to pay part of Merck's legal fees but was excused compensation.
-
UCB files Vimpat patent claims against 15 companies
Aurobindo, Glenmark, Mylan, Ranbaxy and Sandoz all face legal challenge over generic versions of UCB's epilepsy drug. ... These other firms include major players in the generics market, such as Glenmark, Apotex, Mylan, Ranbaxy, Sandoz, Sun Pharma and
-
Merck wins injunction against Januvia generics in India
The patent infringement case against Glenmark centred on the salt form of sitagliptin used in Zita and Zita Met. ... why the courts have blocked Aprica's products whilst letting Glenmark's remain on the market.
More from news
Approximately 5 fully matching, plus 20 partially matching documents found.
Latest appointments
-
Alexion appoints new senior VP for EMEAC region
She was most recently president, international markets at Glenmark Pharmaceuticals, where she led the commercial organisation across the European, Russian, Asian and Latin American regions.
-
Tiziana Life Sciences appoints clinical sciences VP
Dr Evans joins the clinical stage biotechnology company from Glenmark Pharmaceuticals, where he also served as vice president of clinical sciences.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Maloff Mosquito
Client: Glenmark Pharmaceuticals.
-
Jet Off with Maloff Protect
Client: Glenmark Pharmaceuticals.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
PMHub
Research Partnership
Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
